N&N Pharmacare SRL
N&N Pharmacare reported total assets of €1.10m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
By total assets for 2025, N&N Pharmacare ranks among the 10,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of N&N Pharmacare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +5152 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
N&N Pharmacare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
N&N Pharmacare's financial analysis
- Solvency21.5%sector median: 50.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of N&N Pharmacare
N&N Pharmacare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.463.164
- VAT number
- BE0804463164
- Peppol
- Registered · 0208:0804463164 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Aug 2023
- Registered office
- 1160 Auderghem
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
N&N Pharmacare (SRL) has been based in Auderghem since 2023, active in: business and other management consultancy activities. For 2025, it reports a net profit of 202,012 € and equity of 236,143 €; its revenue is not published. Its solvency stands at 21.5%, below the median of its sector (50.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to N&N Pharmacare
Companies in the same business, of comparable size and area, outside its group.
- Prosanitas Business and other management consultancy activities Leuven · balance sheet €1.20m
- Feel Healthy Business and other management consultancy activities Overijse · balance sheet €1.78m
- KNET Business and other management consultancy activities Brasschaat · balance sheet €1.01m
- RP Conseils Business and other management consultancy activities Aubel · balance sheet €1.55m
- ClearView Consulting Business and other management consultancy activities Mechelen · balance sheet 764,976 €
- Mirec Business and other management consultancy activities Beersel · balance sheet €1.71m
- Itrusd Business and other management consultancy activities Overijse · balance sheet €1.66m
- Coreal Business and other management consultancy activities Soignies · balance sheet €1.97m
Frequently asked questions about N&N Pharmacare
What is the revenue of N&N Pharmacare?
N&N Pharmacare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of N&N Pharmacare?
In Belgium, the VAT number is the company number prefixed with BE: BE0804463164 for N&N Pharmacare, if the company is VAT-registered. Its company number (CBE) is 0804.463.164.
Where is the registered office of N&N Pharmacare?
According to the CBE register, the registered office of N&N Pharmacare is in 1160 Auderghem.
What is the equity of N&N Pharmacare?
At the close of the 2025 financial year, the equity of N&N Pharmacare amounts to 236,143 €, a solvency of 21.5% of total assets.
Who manages N&N Pharmacare?
The register lists 1 active mandates at N&N Pharmacare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is N&N Pharmacare within its sector?
By total assets for 2025, N&N Pharmacare ranks among the 10,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of N&N Pharmacare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →